Business
Why the Orthocell (ASX:OCC) share price has popped 6% today
The Orthocell Ltd (ASX: OCC) share price is surging higher today. This comes after the biotechnology company received Australian market approval for its CelGro product. CelGro is a collagen scaffold that supports tissue reconstruction and repair, with a wide range of uses in orthopaedics, general, gynaecology and ENT surgeries.
At the time of writing, the Orthocell share price is up 6% to 43.5 cents.
What’s moving the Orthocell share price?
Investors appear to be pleased with the latest news from the company, pushing the Orthocell share price higher.
With the latest approval, Orthocell can now begin to supply and market CelGro in dental bone and tissue regeneration procedures. According to the company, the CelGro device provides…
-
Noosa News23 hours agoAustralia Zoo reunites with the Ukrainian community
-
Noosa News23 hours ago“Hidden gem”: last chance for renovated bayside homes below $1m
-
General14 hours agoSKorea trade envoy hoping for deal with US by deadline
-
General19 hours agoJannik Sinner reveals secret Wimbledon bet that could keep Darren Cahill in his team